Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM EBITDA Multiple | 18,1x - 20,0x | 19,1x |
Selected Fwd EBITDA Multiple | 11,6x - 12,8x | 12,2x |
Fair Value | ﷼143,35 - ﷼157,94 | ﷼150,65 |
Upside | -13,0% - -4,2% | -8,6% |
Benchmarks | Ticker | Full Ticker |
Mouwasat Medical Services Company | 4002 | SASE:4002 |
Al Hammadi Holding Company | 4007 | SASE:4007 |
Dr. Sulaiman Al Habib Medical Services Group Company | 4013 | SASE:4013 |
Middle East Healthcare Company | 4009 | SASE:4009 |
Dr. Soliman Abdel Kader Fakeeh Hospital Company | 4017 | SASE:4017 |
National Medical Care Company | 4005 | SASE:4005 |
- | - | - |
Select LTM EBITDA Multiple | |||||||
Benchmark Companies | |||||||
4002 | 4007 | 4013 | 4009 | 4017 | 4005 | ||
SASE:4002 | SASE:4007 | SASE:4013 | SASE:4009 | SASE:4017 | SASE:4005 | ||
Historical EBITDA Growth | |||||||
5Y CAGR | 9.4% | 10.5% | 20.3% | 26.1% | 5.9% | 14.9% | |
3Y CAGR | 7.3% | 19.5% | 16.2% | 50.3% | 1.7% | 13.7% | |
Latest Twelve Months | -0.3% | -5.9% | 18.4% | 14.0% | -3.8% | 13.0% | |
Historical EBITDA Profit Margin | |||||||
5 Year Average Margin | 35.5% | 30.9% | 23.9% | 15.2% | 18.9% | 24.9% | |
Prior Fiscal Year | 36.0% | 36.7% | 24.8% | 18.8% | 18.4% | 26.9% | |
Latest Fiscal Year | 33.2% | 34.0% | 24.2% | 21.8% | 16.5% | 24.4% | |
Latest Twelve Months | 33.4% | 33.2% | 24.1% | 21.2% | 15.4% | 25.1% | |
Current Trading Multiples | |||||||
EV / LTM Revenue | 5.39x | 4.84x | 7.98x | 2.55x | 3.51x | 5.18x | |
EV / LTM EBITDA | 16.1x | 14.6x | 33.1x | 12.1x | 22.7x | 20.7x | |
EV / LTM EBIT | 21.2x | 18.5x | 38.9x | 17.6x | 29.8x | 25.6x | |
Low | Mid | High | |||||
Benchmark EV / LTM EBITDA | 12.1x | 16.1x | 33.1x | ||||
Historical EV / LTM EBITDA | 12.5x | 14.5x | 25.0x | ||||
Selected EV / LTM EBITDA | 18.1x | 19.1x | 20.0x | ||||
(x) LTM EBITDA | 346 | 346 | 346 | ||||
(=) Implied Enterprise Value | 6,266 | 6,596 | 6,925 | ||||
(-) Non-shareholder Claims * | 211 | 211 | 211 | ||||
(=) Equity Value | 6,477 | 6,806 | 7,136 | ||||
(/) Shares Outstanding | 44.7 | 44.7 | 44.7 | ||||
Implied Value Range | 144.92 | 152.30 | 159.68 | ||||
FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | |||
Implied Value Range (Trading Cur) | 144.92 | 152.30 | 159.68 | 164.80 | |||
Upside / (Downside) | -12.1% | -7.6% | -3.1% |
Equity Waterfall | |||||||
Benchmark Companies | |||||||
(in millions) | 4002 | 4007 | 4013 | 4009 | 4017 | 4005 | |
Enterprise Value | 15,754 | 5,706 | 94,020 | 7,405 | 9,871 | 7,154 | |
(+) Cash & Short Term Investments | 700 | 291 | 2,548 | 282 | 400 | 677 | |
(+) Investments & Other | 0 | 140 | 469 | 60 | 195 | 0 | |
(-) Debt | (801) | (307) | (8,587) | (2,391) | (1,026) | (466) | |
(-) Other Liabilities | (153) | 0 | (461) | (50) | (393) | 0 | |
(-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
(-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
Value of Common Equity | 15,500 | 5,830 | 87,990 | 5,306 | 9,048 | 7,365 | |
(/) Shares Outstanding | 200.0 | 160.0 | 350.0 | 92.0 | 230.0 | 44.7 | |
Implied Stock Price | 77.50 | 36.44 | 251.40 | 57.65 | 39.34 | 164.80 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 77.50 | 36.44 | 251.40 | 57.65 | 39.34 | 164.80 | |
Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |